Clinical Trial

Fungal Surveillance in Bangladesh

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 22, 2023 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This will be an exploratory descriptive study designed to conduct surveillance for the identification of invasive fungal pathogens among hospitalized patients in Bangladesh at two tertiary care acute-level hospitals. including the Dhaka Medical College Hospital, the Dhaka Hospital of icddr,b, and the National Institute of Cancer Research Hospital (NICRH). Respiratory samples, blood, urine, cerebrospinal fluid, surgical wound infection swabs, and other samples including biopsy tissue specimens will be obtained at intensive care units, general medicine and surgery wards, post-operative care, etc. The collected specimens will be sent to the clinical microbiology laboratories of the surveillance hospitals or to the pathology laboratory (biopsy tissue specimens) to test for Aspergillus, Histoplasms, Candida, Pneumocystis, Cryptococcus, and Mucormycetes. The lab. methods will include microscopy, staining, culture, and biochemical tests mainly and if feasible then some specimens may undergo molecular or immunological methods.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-23.
Trial Details
NCT Number NCT06103331
Lead Sponsor International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborators: Centers for Disease Control and Prevention, Institute of Epidemiology, Disease Control and Research
Conditions Invasive Fungal Infections
Enrollment 800 participants
Start Date 2022-01-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2023-11-22